4//SEC Filing
Varadan Anand 4
Accession 0001209191-18-039409
CIK 0001503802other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:44 PM ET
Size
5.4 KB
Accession
0001209191-18-039409
Insider Transaction Report
Form 4
Varadan Anand
EVP, Chief Commercial Officer
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2018-06-22+150,000→ 150,000 totalExercise: $18.68Exp: 2028-06-21→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 22, 2018. The shares underlying this option vest as to 25% of the shares on June 22, 2019, with the remaining 75% vesting in 36 equal monthly installments.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001650456
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:44 PM ET
- Size
- 5.4 KB